Infections with the parasitic worm W bancrofti associated with increased risk of HIV infection

August 3, 2016, Lancet

People infected with a parasitic worm called Wuchereria bancrofti in areas where HIV is endemic may be more likely to acquire HIV than people who are not infected with the worm, according to a new study in southwest Tanzania, published in The Lancet. W bancrofti causes most cases of lymphatic filariasis (elephantiasis) in sub-Saharan Africa, and the authors say that the findings add a strong argument for tackling this neglected disease, which not only causes morbidity, but may also increase the risk of HIV infection.

Lymphatic filariasis affect one in four people in Tanzania, and has long been suspected to be one of the factors driving the HIV epidemic in sub-Saharan Africa, but previous studies have focused on individuals who are already co-infected with both HIV and . This paper is the first study focusing on HIV susceptibility in individuals with lymphatic filariasis.

W bancrofti is a mosquito borne parasitic worm (or helminth). Worldwide, it causes 90% of lymphatic filariasis cases, a disease commonly known as elephantiasis, which is a neglected tropical disease as defined by the World Health Organisation. Lymphatic filariasis currently affects 120 million people (mostly in Asia, Africa, the western Pacific, and parts of the Caribbean and South America) and causes abnormal enlargement of limbs, causing pain, severe disability and social stigma.

In this study, conducted between 2006 and 2011, the researchers analysed 2699 people in the Kyela district of Mbeya, southwest Tanzania. Participants were visited once annually for 5 years and interviews were conducted to measure behavioural factors involved in HIV acquisition such as sexual activity. Samples of blood, urine, stool, and sputum were collected to test for HIV and for W bancrofti , as well as for Schistosoma haematobium, intestinal helminths, tuberculosis, and malaria.

Participants with lymphatic filariasis were twice as likely to become infected with HIV as those without lymphatic filariasis. Overall, there were 1.91 new HIV infections per 100 person-years in patients with lymphatic filariasis, versus 0.80 new HIV infections per 100 person-years in patients without lymphatic filariasis. Of 1055 HIV-negative patients with lymphatic filariasis, 32 contracted HIV within 3 years, and the effect of lymphatic filariasis was highest among adolescents and young adults, appearing to more than triple the relative risk of HIV acquisition in 14-25-year-olds.

The authors say that although they controlled for HIV risk factors such as sexual behaviour and socioeconomic status, the observational nature of the study means that it does not definitively prove cause and effect, but does add to evidence of an association between lymphatic filariasis and HIV infection. The study controlled for malaria, tuberculosis, and other parasitic infections, but did not find any impact of these factors on the increased risk of HIV acquisition. The authors say this highlights the dominant association with filariasis.

"W bancrofti worms live in the lymphatic system of patients, often without symptoms, for years. The long disease duration of W bancrofti infection (around 10 years) creates an ongoing immune response, which we suspect might leave infected persons more susceptible to HIV infection," explains lead author Dr Inge Kroidl, Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany.

Prevention of W bancrofti infection currently focuses on using mosquito nets and other repellents, as well as treatment with antifilarial drugs such as diethylcarbamazine, albendazole, or ivermectin.

Dr Kroidl adds: "Lymphatic filariasis elimination programmes in the past decade have focused on the reduction of transmission but made only limited efforts to cure W bancrofti infection. Lymphatic filariasis, together with other helminth infections, belongs to the 17 neglected diseases as defined by WHO. Our findings add another argument to push neglected diseases, in this case filarial infection, into the focus of global prevention strategies, as they create not only morbidity but in addition may generate an increased risk of acquiring HIV."

A number of other infections such as chlamydia, herpes, and syphilis are known to increase susceptibility to HIV. The most effective and evidence-based methods of reducing HIV transmission are the use of condoms, male circumcision, pre-exposure prophylaxis, HIV screening and limiting the number of sexual partners.

Writing in a linked Comment, Jennifer A Downs and Daniel W Fitzgerald, of the Center for Global Health, Department of Medicine, Weill Cornell Medicine, New York, USA, say: "Helminth infections, such as lymphatic filariasis, schistosomiasis, and intestinal nematodiases, are classified by WHO as neglected tropical diseases. For years, these neglected tropical diseases have received minimal global attention and less than 1% of global research funding...Kroidl and colleagues' study helpfully points the way toward a more robust consideration of the interactions between parasitic infections and HIV. At least two urgent action points emerge from their findings. First, the study emphasises a need for trials to assess the effect of antifilarial treatment on HIV incidence in endemic communities. Controlling has the potential not only to decrease morbidity from the disease itself, but could additionally prevent incident HIV infections among the 120 million people living with this chronic infection. Second, this research calls for further studies to assess the impact of other helminth infections, individually and in concert, on HIV incidence. Do not 2 billion people living with these neglected tropical diseases, who might be at increased risk of HIV infection, deserve such attention?"

Explore further: New test better detects elephantiasis worm infection

More information: The Lancet, www.thelancet.com/journals/lan … rticle/PIIS0140-6736

Related Stories

New test better detects elephantiasis worm infection

May 20, 2013
A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field study in Liberia, ...

New anti-HIV medication provides protection for women and infants

August 1, 2016
HIV remains a major health concern for women and children globally. Worldwide, the majority of new HIV infections occur in young women. Each year, 1.5 million women living with HIV become pregnant. Without effective treatment, ...

Disease-carrying mosquitos pack twice the punch

June 17, 2013
An international team of researchers from the University of Notre Dame's Eck Institute for Global Health and Imperial College London has recently published its work on a malaria-filaria co-transmission model, where the same ...

A predictive risk map for the nematode parasite Mansonella perstans in Uganda

January 21, 2016
Infection with the nematode parasite Mansonella perstans is one of the most neglected of the neglected tropical diseases. Although symptoms are usually mild, the infection can cause swelling, fever, headaches and abdominal ...

Prisoners pose biggest risk for HIV infection rates in Eastern Europe

July 27, 2016
Prisoners are likely to be the primary risk group for HIV infections in Eastern Europe in the next 15 years, researchers from the University of Bristol have found.

Recommended for you

FRESH program combines basic science with social benefits for women at risk of HIV

September 14, 2018
A program established by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from ...

New study finds HIV outbreak in Indiana could have been prevented

September 13, 2018
An HIV outbreak among people who inject drugs in Indiana from 2011 to 2015 could have been avoided if the state's top health and elected officials had acted sooner on warnings, a new study by the Yale School of Public Health ...

Largest study of 'post-treatment controllers' reveals clues about HIV remission

September 13, 2018
Most HIV patients need to take daily anti-retroviral therapy—if they suspend treatment, HIV will rebound within 3-4 weeks. But clinical trials have revealed that a small fraction of patients can stop taking medications ...

Very few sexually active gay and bisexual men use prophylactic drug to prevent HIV transmission, study finds

September 12, 2018
Only 4 percent of sexually active gay and bisexual men in the United States use Truvada, a highly effective medication used to prevent the transmission of HIV, according to the results of a first-of-its-kind study.

Special antibodies could lead to HIV vaccine

September 10, 2018
Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the ...

Researchers date 'hibernating' HIV strains

September 5, 2018
Researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) and Simon Fraser University (SFU), in partnership with University of British Columbia (UBC) and Western University, have developed a novel way for dating "hibernating" ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.